Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma
Crossref DOI link: https://doi.org/10.1186/s13045-016-0286-x
Published Online: 2016-07-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Liping
Zhao, Ningning
Xu, Wenjun
Sheng, Zhixin
Wang, Lida